HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BSE tallow exemption

This article was originally published in The Rose Sheet

Executive Summary

Approved by the European Commission March 5. As expected, the exemption eliminates tallow from the European Union's ban on the use of all specified risks materials (SRMs) derived from sources potentially afflicted with transmissible spongiform encephalopathies. As a requirement of the exemption, tallow and its derivatives must be processed using methods designated by the Scientific Committee on Cosmetic and Non-Food Products. The ban is scheduled to go into effect April 1. The European Cosmetic, Toiletry and Perfumery Association (COLIPA) said it is "very pleased" with the announcement, pointing out that the amendment is the "first clear piece of legislation" providing an exemption on the SRM ban for an entire industry. The legislation allows the use of tallow derivatives in personal care products while "ensuring consumer safety," COLIPA added...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005213

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel